Nobel Prize Fighter A man on a mission to get share of MRI credit By James Bernstein, Mark Harrington and Earl Lane STAFF WRITERS October 21, 2003 The daily prayer service at FONAR Corp. begins at 9 o'clock to strains of the national anthem. And as they have on weekday mornings for the past decade, a group of FONAR workers and executives head to a small area of a shop floor. For the next 20 minutes, about 15 people listen as FONAR's human resources director, Fred Peipman, reads Scripture and gives thanks. "We thank you for Dr. Damadian and his invention and the bread it puts on our tables," Peipman says in closing, referring to FONAR's chairman and founder, Raymond Damadian, an inventor who realized that a phenomenon called magnetic resonance could be useful in scanning tissue for signs of cancer. It may be an article of faith at the Melville medical technology company that their founder created the MRI scanner. But that's not how it was for the Nobel committee that recently ignored Damadian when it handed out honors for development of the machine. And now FONAR's leader - a man full of strong opinions and contradictions - is on a crusade to make his case. The 67-year-old, white-haired Damadian is a multimillionaire, but still lives in a colonial in Woodbury he bought decades ago. He is a trained physician, but favors a theory of creationism over evolution. Though CEO of the company, Damadian's salary is $85,000 and he takes no bonus - and says he will not until the company turns a profit. And while Damadian's career and company is built around his pioneering work with the MRI, he has been unable to persuade the scientific community that he deserved a Nobel prize to secure his place in medical history. Hans Jornvall, secretary of the Nobel Assembly at the Karolinska Institute in Sweden that selects the winners of the prize for medicine, said Damadian's actions are unusual. While the assembly has received critical comments on past awards, he said, "I have never seen large-scale advertisements against us before," Jornvall said. The prize decision is final, he said, and based on a careful review of the scientific literature. "Once we have taken a vote, we have taken a vote," Jornvall said. And that vote awarded the prize to two others, including a man Damadian has considered a nemesis for the past 30 years, Paul Lauterbur of the University of Illinois. Lauterbur did his prize-winning work while he was at Stony Brook University. The other winner was British citizen Sir Peter Mansfield of the University of Nottingham. It's a decision that most in the scientific community think is correct based on the scientific facts, according to several specialists. But on Oct. 9 Damadian took out a full-page ad in The Washington Post, followed the next day by ads in The New York Times and Los Angeles Times, blasting the Nobel committee for not giving him a share of the $1.3 million prize for medicine. The ads, which showed an inverted Nobel prize medal, accused the committee of "attempting to rewrite history." The ads asked the public to petition the committee to include him in the prize. Full-page ads ran again yesterday in the New York Times and in Dagens Nyheter, Sweden's second-largest morning newspaper. Many scientists and others have protested Nobel awards in the 100 years the prizes have been issued, but Damadian's actions were considered audacious by almost any measure. But then again, Damadian has spent much of his professional life rubbing colleagues the wrong way. "Damadian deserved to be considered" for the Nobel, said Stephen Thomas, a past president of the American Association of Physicists in Medicine. But Thomas, who assumes the Nobel committee did its homework, added that regarding Damadian: "From the point of view of personality, he hasn't pushed his position in what would be considered, in my view, a logical way. He's always been at odds with the field." Damadian has never shied away from the limelight, his friends say. The recent controversy he has generated in the medical and scientific community has seemed only to add spark to his step. On a recent afternoon, Damadian strode briskly into the Sweet Hollow Diner in Melville with all the rumpled glamour of an aging prize fighter, his trademark white mane and mustache turning heads, either from vague recognition or the mistaken sense that he is bull-charging them. Holding a cup of coffee he has carried from his office, he nods genially when the smiling proprietor says he has seen him in the papers again. Damadian tucks himself into a corner booth and continues a monologue that never faltered. When the waitress asks what he'll drink, he says, "corned-beef sandwich." Later, still speaking, he holds the sandwich like a pointer or a stick of chalk, and a large piece of corned beef swings at the bottom of his sandwich but it never falls off. The short car ride with a reporter had been something of a journey, Damadian recounting in striking detail the events that led to the rescue of his young Armenian father from the slaughter by the Turks in the Syrian desert during World War I. He remembered not only the names of the specific sections of desert where the shattered family was marched, but the spelling of them, veering out of his lane in his weathered white Continental as he turned to a listener to make a point more emphatic. The feistiness comes through in the current fight. "There isn't anybody out there who wouldn't give me credit for challenging the establishment," Damadian said the other day in an interview in a cluttered FONAR conference room, a smile crossing his face. "I've always had to withstand the brickbats," said Damadian. A Child Prodigy Damadian has long stood out from his friends and classmates, often taking unpredictable paths. The son of musical parents, Damadian studied violin at Juilliard for nearly a decade but did not pursue it as a career. Charlie Brukl, who met Damadian when both were young tennis-playing teenagers growing up in Forest Hills and who is now FONAR's director of materials research, said his friend was always a top student with a serious demeanor. Damadian graduated from the Albert Einstein College of Medicine in the Bronx and later joined the faculty of the State University of New York Downstate Medical Center in Brooklyn. "He has a determination to succeed beyond and above anybody else I've known in the science and medical community," said Brukl. "If he gets an idea, he rarely lets anyone tell him it can't be done." People who know Damadian say he is complex, often seemingly contradictory. A trained scientist, Damadian believes the world is only 6,000 years old and debunks the theory of evolution. "We are asked to believe all modern life oozed out of the bottom of the sea," Damadian said, warming up to one of his favorite subjects - how the world began. "That's preposterous." An intensely religious Protestant, Damadian is nonetheless anything but humble. On that issue, Damadian quotes Edmund Burke, the 18th century Scottish philosopher and British parliamentarian, who said, "Evil triumphs when good men do nothing." By this, Damadian means he could not sit back and allow the Nobel committee to exclude him. "I'm focused on not being written out of history," Damadian said the other day. "Otherwise, every textbook from here on out will say the MRI was invented by Lauterbur and Mansfield." And preventing that has become the passion of his life these days, even though Damadian readily concedes there is virtually no chance the Nobel committee will reverse itself and add his name alongside the two others who won this year for medicine. In fact, he says, he no longer wants a Nobel prize. "The Nobel prize now has a corrupt significance to me," Damadian said. "It has the stain of Cain on it." He just wants to let the world know that, according to Damadian and his supporters, he played a key and pivotal role in developing MRI technology, and that he should not be forgotten by history. Diatribe at a Meeting In 1969 while at Downstate, Damadian had an opportunity to use a nuclear magnetic resonance spectrometer in his biophysics research. He got an idea to build an NMR large enough to scan the human body, so it could detect cancer cells. In 1971, he published a paper in the journal Science on experiments with lab rats showing that NMR signals from cancerous tissue differed from those of normal tissue. In medical usage, the MRI technique takes advantage of the fact that the human body, by weight, is about two-thirds water. When the body is exposed to a strong magnetic field, the hydrogen nuclei in the water orient themselves. When submitted to a pulse of radio waves, the energy content of the nuclei changes and as they relax to their previous states, a resonance wave is emitted. Summaries of the history of MRI typically cite Damadian's early role in recognizing that magnetic resonance could be used in medical diagnosis on body tissues. Damadian's supporters maintain that from that insight, all future developments in MRI flow. But many scientists say that Lauterbur and Mansfield made the conceptual advances that permitted the development of the MRI machines now used around the world. Damadian, who was awarded a patent on Feb. 5, 1974, for an "Apparatus and Method for Detecting Cancer in Tissue," pursued commercialization of MRI on his own, while Lauterbur was unable to persuade officials of the State University of New York system to apply for a patent based on his early imaging research. For many MRI specialists, Damadian has long been a controversial figure whose difficult personality and categorical statements regarding his contributions have alienated colleagues who might otherwise feel more sympathy regarding his exclusion from the Nobel prize. "As I look back, if Dr. Damadian hadn't been so vitriolic in his attacks on other people, I would have argued that he deserved to be included" in the prize, said Dr. Gary Fullerton, an MRI specialist at the University of Texas Health Sciences Center in San Antonio. "He created this situation himself." Fullerton, founding editor of "The Journal of Magnetic Resonance Imaging," recalled a scientific meeting in London in 1985. "There was a conscious effort on the part of the Society of Magnetic Resonance in Medicine to pull Dr. Damadian back into the fold," Fullerton said. Ian Young, a British MRI expert who was a local organizer of the meeting, said Damadian "had promised he would behave himself" while serving as moderator of a key session with several hundred scientists in attendance. Instead, Young said, Damadian "started giving this diatribe" against Lauterbur. "People were absolutely shocked that he did it," Fullerton said. "That sort of behavior really doesn't set well with scientists." Lauterbur declined to discuss any matters involving Damadian. Dr. David Stark, a radiologist at Downstate, who is a strong backer of Damadian, said his behavior at the London meeting was "inappropriate." But Stark said Damadian deserved recognition by the Nobel committee, whatever his relations with other researchers. "For just being a clumsy, pushy New Yorker, he was screwed," Stark said. Damadian took on corporations as well as the scientific community, filing patent infringement lawsuits against companies he felt were stealing his ideas. One judgment, upheld by the Supreme Court in 1997, ordered General Electric to pay Damadian $128.7 million. Damadian said that all of the money from that and other suits has been put back into the company for research and development purposes. Damadian is FONAR's largest shareholder, with about 8 percent of the company's stock. His stock holdings amount to about $6.5 million. Damadian said he also receives "a few hundred thousand dollars" of income a year from the 15 scanning centers he has established around the country. In the patent case, some experts questioned whether the courts fully understood some of the technical issues being argued. Damadian points to such rulings as buttressing his arguments, but others are dismissive. "Scientists don't go around looking for information in patent literature," said Paul Bottomley, an MRI expert at Johns Hopkins University who has worked with Mansfield. "Scientists look at journals." Weighing the Competing Claims Thomas, the past president of the American Association of Physicists in Medicine who is also an MRI expert at the University of Cincinnati Medical Center, said Damadian's 1971 paper in the journal Science "really sort of laid the groundwork for using magnetic resonance parameters in diagnosis." Other scientists already had showed that when atomic nuclei subjected to a magnetic field return to their previous energy levels, their "relaxation" times can be measured in two forms, dubbed T1 and T2, that can give information on the structure of the sample. Damadian devised a way of using the T1 and T2 measurements to detect cancerous tissue in the body. He surgically removed fast-growing tumors from lab rats and showed that their signals differed from those of normal tissue. "Damadian's main contribution was to observe that one nuclear magnetic resonance property, relaxation time, was elevated in cancerous tissue compared to normal tissue," Bottomley said. But several specialists said Damadian's original work had some flaws. As it later turned out, relaxation rates are not a reliable indicator of cancer. "He made the statement you could distinguish cancer because it has longer relaxation times," Fullerton said. "That's very non-specific. ... Tumors do cause that, but other infections and diseases do the same thing." And Damadian's design for a scanner used a point-by-point method that proved cumbersome and did not produce useful images. "Damadian had a single spot he was moving the sample through," Bottomley said. Lauterbur realized he could subject the atomic nuclei to a second, weaker magnetic field along with the first field to produce what is called a magnetic field gradient. That gradient, varying in intensity at different points in the sample, served as the basis for the MRI machines used in medical practice, including even those manufactured by Damadian's own company, experts said. Mansfield further developed the gradient method, showing how the signals could be mathematically analyzed to produce two-dimensional slices of the human body. He also showed how to greatly speed up the imaging process. Several experts said the Nobel committee made the right decision in awarding the prize only to Lauterbur and Mansfield. "There is a real issue," said one longtime MRI specialist who asked not to be identified because he did not want to tangle publicly with Damadian. "The issue is whether Damadian is correct" in challenging the prize committee. "The fact that he is obnoxious or aggressive, that doesn't make him unique. The fact that he's in industry rather than academia, that's not the issue. The issue is did the Nobel prize committee fail to include a person whose scientific discoveries were essential to the invention being honored? I think the answer to that is very clear. If what you are trying to honor is the workable imaging machines which are used around the world and have a big role in medicine, it is appropriate to honor the invention which makes it possible. That is the field gradient." Said Bottomley: "Most of the scientists in the field would recognize that the award was correct." Bottomley and others argue that Lauterbur and Mansfield made the fundamental advances that turned MRI into a practical method now widely used in medicine. "The prize was given for the development of MRI imaging in its present form," Young said. "Raymond contributed nothing to that at all." Thomas dismissed Damadian's comment to one reporter that if he had not been born, MRI would not exist today. "Nobody is indispensable," Thomas said. "People were working with magnetic resonance in biology before he picked it up." John Throck Watson, a professor of biochemistry at Michigan State University, said Damadian deserved recognition for making discoveries that spurred the subsequent development of practical imaging devices. He said the Nobel committee had an opportunity to include him, since a prize can be awarded to as many as three people. Young said the Damadian-inspired controversy may have led the Nobel committee to delay the prize for MRI longer than some specialists had anticipated. "We all put it down to the fact that the committee was aware it was going to be very hard to make an award that would be accepted without a row," Young said. Even if Damadian had won the prize, he said, "I don't think it would have shut Raymond up." Damadian says that he intends to remain active in the field of medical research, and envisions a day when MRI scanners will be the size of living rooms, allowing doctors to produce large-scale, detailed pictures of the insides of the human body. "The direction I get from my prayers is to stay the course," Damadian said. "I feel I would be disobeying if I didn't." Copyright © 2003, Newsday, Inc.